BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1 AND Diagnosis
9 results:

  • 1. Clinicopathological analysis of rosette-forming glioneuronal tumors.
    Liu J; Lin F; Sun Y; Liu X
    Diagn Pathol; 2024 Feb; 19(1):39. PubMed ID: 38388383
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants.
    De Bortoli M; Ivars M; Revencu N; Nassogne MC; Lavarino C; Paco S; Lammens M; Renders A; Dumitriu D; Helaers R; Boon LM; Baselga E; Vikkula M
    Am J Med Genet A; 2024 Jun; 194(6):e63551. PubMed ID: 38321651
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
    Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
    Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours.
    Appay R; Bielle F; Sievers P; Barets D; Fina F; Boutonnat J; Adam C; Gauchotte G; Godfraind C; Lhermitte B; Maurage CA; Meyronet D; Mokhtari K; Rousseau A; Tauziède-Espariat A; Tortel MC; Uro-Coste E; Burel-Vandenbos F; Chotard G; Pesce F; Varlet P; Colin C; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12813. PubMed ID: 35293634
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Rosette-Forming Glioneuronal Tumor in the Pineal Region: A Series of 6 Cases and Literature Review.
    Lin CC; Mansukhani MM; Bruce JN; Canoll P; Zanazzi G
    J Neuropathol Exp Neurol; 2021 Oct; 80(10):933-943. PubMed ID: 34498065
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Next-generation whole exome sequencing of glioblastoma with a primitive neuronal component.
    Xu G; Zheng H; Li JY
    Brain Tumor Pathol; 2019 Jul; 36(3):129-134. PubMed ID: 30715630
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.
    Williams EA; Miller JJ; Tummala SS; Penson T; Iafrate AJ; Juratli TA; Cahill DP
    Acta Neuropathol Commun; 2018 Oct; 6(1):106. PubMed ID: 30333046
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
    Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
    Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma.
    Nikbakht H; Panditharatna E; Mikael LG; Li R; Gayden T; Osmond M; Ho CY; Kambhampati M; Hwang EI; Faury D; Siu A; Papillon-Cavanagh S; Bechet D; Ligon KL; Ellezam B; Ingram WJ; Stinson C; Moore AS; Warren KE; Karamchandani J; Packer RJ; Jabado N; Majewski J; Nazarian J
    Nat Commun; 2016 Apr; 7():11185. PubMed ID: 27048880
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.